Sodium‐glucose co‐transporter 2 inhibitors and hematopoiesis
Autor: | Habib Yaribeygi, Mina Maleki, Fatemeh Nasimi, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Journal of Cellular Physiology. 237:3778-3787 |
ISSN: | 1097-4652 0021-9541 |
Popis: | Many patients with diabetes mellitus, especially those with chronic kidney disorders, have some degree of anemia due to a spectrum of causes and underlying pathophysiologic pathways. As such, enhancement in erythropoiesis is important in these patients. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a relatively new class of antidiabetic drugs with confirmed protective effects in kidney and cardiovascular tissues. Recent evidence suggests that these drugs may provide additional benefits in enhancing hematopoietic processes in diabetic patients. Though the exact mediating pathways have not been fully elucidated, cellular mechanisms are likely involved. In the current study, we present the potential pathways by which SGLT2i may modulate hematopoiesis and stimulate erythropoiesis. |
Databáze: | OpenAIRE |
Externí odkaz: |